CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.

about

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.

Item

http://www.wikidata.org/entity/Q47125786

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@en

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@nl

type

Item

label

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@en

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@nl

prefLabel

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@en

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@nl

P1476

CD24, CD27, CD36 and CD302 gen ...... atients with multiple myeloma.

@en

P2093

Anja Seckinger

http://www.w3.org/2001/XMLSchema#string

Bernard Klein

http://www.w3.org/2001/XMLSchema#string

Elina Alaterre

http://www.w3.org/2001/XMLSchema#string

Guilhem Requirand

http://www.w3.org/2001/XMLSchema#string

Jérôme Moreaux

http://www.w3.org/2001/XMLSchema#string

Nicolas Robert

http://www.w3.org/2001/XMLSchema#string

Salahedine Bouhya

http://www.w3.org/2001/XMLSchema#string

Sebastien Raimbault

http://www.w3.org/2001/XMLSchema#string

Stéphanie Boireau

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?

CD109 plays a role in osteoclastogenesis

Modeling risk stratification in human cancer.

GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.

Soluble CD16 in plasma cell dyscrasias.

International staging system for multiple myeloma.

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.

P304

98931-98944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22131

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut Goldschmidt

Dirk Hose

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228738

http://www.w3.org/2001/XMLSchema#string

P932

5716778

http://www.w3.org/2001/XMLSchema#string